The impact of a recent relapse on patient-reported outcomes in subjects with multiple sclerosis

Quality of Life Research

Volumn 21, Issue 10, 2012, Pages 1677-1684

  Healy, Brian C ^a,b,c   Degano, Irene R ^a   Schreck, Ana ^a   Rintell, David ^a,b   Weiner, Howard ^a,b   Chitnis, Tanuja ^a,b   Glanz, Bonnie I ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clinical relapse; Depression; Fatigue; Health related quality of life; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; DEPRESSION; FATIGUE; FEMALE; HUMAN; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX;

ADULT; DEPRESSION; FATIGUE; FEMALE; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROGNOSIS; QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 84872346001     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-011-0108-0     Document Type: Article

References (24)

1. Hemmett, L., Holmes, J., Barnes, M., & Russell, N. (2004). What drives quality of life in multiple sclerosis? QJM, 97(10), 671-676.
2. Nortvedt, M. W., Riise, T., Myhr, K. M., & Nyland, H. I. (1999). Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology, 53(5), 1098-1103.
3. Hermann, B. P., Vickrey, B., Hays, R. D., Cramer, J., Devinsky, O., Meador, K., et al. (1996). A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Research, 25(2), 113-118.
4. Hviid, L. E., Healy, B. C., Rintell, D. J., Chitnis, T., Weiner, H. L., & Glanz, B. I. (2011). Patient reported outcomes in benign multiple sclerosis. Multiple Sclerosis, 17(7), 876-884.
5. Ford, H. L., Gerry, E., Johnson, M. H., & Tennant, A. (2001). Health status and quality of life of people with multiple sclerosis. Disability and Rehabilitation, 23(12), 516-521.
6. Pittock, S. J., Mayr, W. T., McClelland, R. L., Jorgensen, N. W., Weigand, S. D., Noseworthy, J. H., et al. (2004). Quality of life is favorable for most patients with multiple sclerosis: A populationbased cohort study. Archives of Neurology, 61(5), 679-686.
7. Pfennings, L., Cohen, L., Ader, H., Polman, C., Lankhorst, G., Smits, R., et al. (1999). Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. Journal of Neurology, 246(7), 587-591.
8. Rudick, R. A., Miller, D., Hass, S., Hutchinson, M., Calabresi, P. A., Confavreux, C., et al. (2007). Health-related quality of life in multiple sclerosis: Effects of natalizumab. Annals of Neurology, 62(4), 335-346.
9. Lublin, F. D., Baier, M., & Cutter, G. (2003). Effect of relapses on development of residual deficit in multiple sclerosis. Neurology, 61(11), 1528-1532.
10. Kalb, R. (2007). The emotional and psychological impact of multiple sclerosis relapses. Journal of the Neurological Sciences, 256(Suppl 1), S29-S33.
11. Halper, J. (2007). The psychosocial effect of multiple sclerosis: The impact of relapses. Journal of the Neurological Sciences, 256(Suppl 1), S34-S38.
12. Orme, M., Kerrigan, J., Tyas, D., Russell, N., & Nixon, R. (2007). The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK. Value in Health, 10(1), 54-60.
13. Parkin, D., Jacoby, A., McNamee, P., Miller, P., Thomas, S., & Bates, D. (2000). Treatment of multiple sclerosis with interferon beta: An appraisal of cost-effectiveness and quality of life. Journal of Neurology, Neurosurgery and Psychiatry, 68(2), 144-149.
14. Bethoux, F., Miller, D. M., & Kinkel, R. P. (2001). Recovery following acute exacerbations of multiple sclerosis: From impairment to quality of life. Multiple Sclerosis, 7(2), 137-142.
15. Nortvedt, M. W., Riise, T., Myhr, K. M., & Nyland, H. I. (2000). Quality of life as a predictor for change in disability in MS. Neurology, 55(1), 51-54.
16. Gauthier, S. A., Glanz, B. I., Mandel, M., & Weiner, H. L. (2006). A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB study. Autoimmunity Reviews, 5(8), 532-536.
17. Gorman, M. P., Healy, B. C., Polgar-Turcsanyi, M., & Chitnis, T. (2009). Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Archives of Neurology, 66(1), 54-59.
18. Ware, J. E., Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473-483.
19. Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401.
20. Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994). The impact of fatigue on patients with multiple sclerosis. Canadian Journal of Neurological Sciences, 21(1), 9-14.
21. Ritvo, P., Fischer, J., Miller, D., Paty, D., & LaRocca, N. (1997). Multiple sclerosis quality of life inventory: A user's manual. New York, NY: National Multiple Sclerosis Society.
22. Efron, B., & Tibshirani, R. (1993). An introduction to the bootstrap. New York, NY: Chapman & Hall.
23. Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care, 41(5), 582-592.
24. Freedman, M. S., Patry, D. G., Grand'Maison, F., Myles, M. L., Paty, D. W., & Selchen, D. H. (2004). Treatment optimization in multiple sclerosis. Canadian Journal of Neurological Sciences, 31(2), 157-168.